Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- DMSO (>30mg/ml), methanol, water (>30mg/ml)
Category: API's & Intermediates
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
(S)-(+)-Clopidogrel is a prodrug that is metabolized by cytochrome P450 isoforms to produce an active metabolite, which is a selective, irreversible high-affinity antagonist of the platelet purinergic P2Y12 receptor. Potent antithrombotic antiplatelet agent. By inhibiting the Purinoceptor P2Y12 subtype it consequently inhibits ADP-induced platelet aggregation. (S)-(+)-Clopidogrel hydrogen sulfate is the active isomer. Compound can be used as analytical reference material.
| Synonyms | Clopidogrel bisulfate, Clopidogrel Hemisulfate, SR 25990C, (S)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogensulfate |
|---|---|
| Purity | ≥98% (HPLC) |
| Appearance | White to off-white powder |
| CAS-Number | 120202-66-6 |
| Molecular Formula | C16H16ClNO2S · H2SO4 |
| Molecular Weight | 419.90 |
| Identity | 1H-NMR |
| Solvents | DMSO (>30mg/ml), methanol, water (>30mg/ml) |
| Smiles | ClC1=CC=CC=C1[C@H]([NH+]2CCC(SC=C3)=C3C2)C(OC)=O.[O-]S(=O)(O)=O |
| InChi Key | FDEODCTUSIWGLK-UHFFFAOYSA-N |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Hazard statements | H300-H314-H411 |
| Precautionary statements | P260-P280-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338 |
| GHS Symbol | GHS05+GHS06+GHS09 |
| Signal word | Danger |
| RIDADR | 2928 6.1(8) |
| Transportation | Packing Group I |
| References | (1) D.C.B. Mills, et al., Arterioscler. Thromb. 12, 430 (1992), (2) G. Feuerstein, et al., Exp. Opin. Invest. Drugs 4, 425 (1995), (3) P. Savi, et al., BBRC 283, 379 (2001), (4) P. Savi & J.M. Herbert, Se≥ Thromb. Haemostas. 31, 174 (2005), (5) I. von Kugelgen, Pharmacol.Ther. 110, 415 (2006), (6) N. Ferri, et al., Drugs 73, 1681 (2013) |
| Quantity | 250 mg, Bulk |

DAR-4M solution (5 mM in DMSO), 1 mg in 0.46 ml DMSO